Blocking CD44 by genetic ablation or antibody antagonism attenuates adipose tissue inflammation, fibrosis, and insulin resistance with increased adiposity in obese mice (Kang et al. 2013, Kodama et al. 2015). This evidence concerns the gene CD44 and Insulin resistance.